This is a preview of subscription content, log in via an institution to check access.
References
Balamurugan V, Hosamani M, Jayappa K D, Venkatesan B, Chauhan R, Singh A. 2009. A polymerase chain reaction strategy for the diagnosis of camelpox. Vet Diag Invest, 21: 231–237.
Binns M, Mumford J, Wernery W. 1992. Analysis of the Camelpox virus thymidine kinase gene. Br Vet J, 148: 541–546.
Dietzschold B, Wunner W H, Wiktor T J, Lopes A D, Lafon M, Smith C L, Koprowski H. 1983. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci. USA, 80:70–74.
Duraffour S, Meyer H, Andrei G, Snoeck R. 2011. Camelpox virus. Antiviral Res, 92(2):167–86.
Hafez S M, Al-Sukayran A, Dela Cruz D M, Mazloum K S, Al-Bokmy A M, Al-Mukayel A, Amjad A M. 1992. Development of a live cell culture camelpox vaccine. Vaccine, 10: 533–537.
Khalafalla A I, Mohamed M E M. 1996. Clinical and epizootiological features of camelpox in eastern Sudan. J Camel Pract and Res, 2: 99–102.
Khalafalla A I, Mohamed M E H, Ali B H. 1998. Camel pox in the Sudan. 1-isolation and identification of the causative virus. J Camel Pract and Res, 5: 229–233.
Laidlaw S M, Skinner M A. 2004. Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses. J Gen Virol, 85: 305–322.
Massung R F, Esposito J J, Liu L Q, Utterback T R, Knight J C, Aubin L, Yuran T E, Parsons J M, Loparev V N, Selivanov N A, Cavallaro K F, Kerlavage A R, Mahy B W, Venter J C. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature, 366: 748–751.
Monath T P. 2005. Yellow fever vaccine. Expert Rev. Vaccines, 4: 553–574.
Nguyen Ba-Vy, Guerre L, Martin-Sant G. 1996. Etude preliminaire de I innocuite e du pouvoir immunogene de la ouche attenuee VD47/25 de camelpox virus. Revue de Elev Med Vet Pays trop, 49: 189–194.
Perkus M E, Goebel S J, Davis S W, Johnson G P, Limbach K, Norton E K, Paoletti E. 1991. Deletion of 55 open reading frames from the termini for vaccinia virus. Virology, 180: 406–410.
Pfeffer M, Meyer H, Wernery U, Kaaden O R. 1996. Comparison of camelpox viruses isolated in Dubai. Vet Microbiol, 49: 135–146.
Singh R K, Balamurugan V, Hosamani M, Kallesh D J, Bhanuprakash V. 2008. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses. J Virol Methods, 154(1–2):146–153.
Tulman E R, Afonso C L, Lu Z, Zsak L, Sur J H, Sandybaev N T, Karembekova U Z, Zaitsev V L, Kutish G F, Rock D L. 2002. The genomes of sheeppox and goatpox viruses. J Virol, 76: 6054–6061.
Westrop G D, Wareham K A, Evans D M, Dunn G, Minor P D, Magrath D I, Taffs F, Marsden S, Skinner M A, Schild G C, Almond J W. 1989. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol, 63: 1338–1344.
Wernery U, Kaaden O R. 2002. Camel pox. In: Infectious Diseases in Camelids, Second Edition, Wernery U, Kaaden O R, eds, Blackwell Science Berlin, Vienna: 176–185.
Wernery U, Zachariah R. 1999. Experimental camelpox infection in vaccinated and unvaccinated dromedaries. J Vet Med (B) Infect Dis, 46: 131–136.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdellatif, M.M., Salim, B., Ibrahim, A.A. et al. Analysis of TK and C18L genes of wild-type and cell culture passaged camelpox virus. Virol. Sin. 28, 239–241 (2013). https://doi.org/10.1007/s12250-013-3329-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-013-3329-2